What is Welwaze?
Welwaze Medical is dedicated to improving lives through technology by developing advanced medical devices that enhance care management capabilities. Their flagship product, Celbrea, is a breast thermal activity indicator designed for early detection of breast disease, used by healthcare professionals alongside traditional examination methods. The company aims to empower individuals from all communities to take charge of their health by making health data more accessible. Recognized for their innovative contributions, Welwaze Medical strives to be a human-first company in the MedTech industry, focusing on accessible health data and early disease detection.
How much funding has Welwaze raised?
Welwaze has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Welwaze
PPP
Public-Private Partnership
What's next for Welwaze?
With its recent large-scale, late-stage funding, Welwaze is poised for significant expansion and further development of its innovative medical devices. The strategic investment signals a move towards scaling operations and potentially broadening the reach of its Celbrea product. This capital infusion will likely fuel advancements in their technology, enhance market penetration, and solidify their position as a leader in the MedTech sector, particularly in early disease detection and accessible health data solutions.
See full Welwaze company page
